392,400 Shares in MeiraGTx Holdings plc (NASDAQ:MGTX) Purchased by Garden State Investment Advisory Services LLC

Garden State Investment Advisory Services LLC bought a new position in shares of MeiraGTx Holdings plc (NASDAQ:MGTX) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 392,400 shares of the company’s stock, valued at approximately $1,636,000. Garden State Investment Advisory Services LLC owned 0.50% of MeiraGTx as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the stock. Knoll Capital Management LLC bought a new stake in MeiraGTx in the third quarter valued at approximately $5,212,000. Erste Asset Management GmbH acquired a new stake in MeiraGTx during the 3rd quarter worth $2,795,000. Privium Fund Management B.V. lifted its holdings in MeiraGTx by 70.0% during the second quarter. Privium Fund Management B.V. now owns 203,960 shares of the company’s stock worth $804,000 after acquiring an additional 83,975 shares in the last quarter. Barclays PLC grew its stake in MeiraGTx by 107.1% in the third quarter. Barclays PLC now owns 147,827 shares of the company’s stock valued at $618,000 after acquiring an additional 76,437 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in shares of MeiraGTx by 14.6% in the second quarter. Dimensional Fund Advisors LP now owns 462,950 shares of the company’s stock worth $1,949,000 after acquiring an additional 58,854 shares in the last quarter. Institutional investors and hedge funds own 67.48% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on MGTX. Royal Bank of Canada lifted their price objective on MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a report on Thursday, November 14th. Chardan Capital restated a “buy” rating and set a $36.00 price objective on shares of MeiraGTx in a research note on Monday, November 18th.

MeiraGTx Stock Performance

MGTX traded up $0.10 during trading on Friday, hitting $6.11. The stock had a trading volume of 36,855 shares, compared to its average volume of 203,013. MeiraGTx Holdings plc has a one year low of $3.85 and a one year high of $7.60. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34. The firm has a market cap of $477.51 million, a price-to-earnings ratio of -4.97 and a beta of 1.25. The company has a 50 day moving average price of $5.92 and a 200-day moving average price of $4.93.

MeiraGTx Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.